Ken Griffin’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-144,449
| Closed | -$27.6K | – | 12991 |
|
|
2025
Q3 | $27.6K | Buy |
144,449
+90,410
| +167% | +$108K | ﹤0.01% | 12422 |
|
|
2025
Q2 | $91.9K | Sell |
54,039
-28,084
| -34% | -$47.4K | ﹤0.01% | 11409 |
|
|
2025
Q1 | $130K | Sell |
82,123
-76,918
| -48% | -$130K | ﹤0.01% | 11089 |
|
|
2024
Q4 | $285K | Buy |
159,041
+130,562
| +458% | +$416K | ﹤0.01% | 9759 |
|
|
2024
Q3 | $173K | Buy |
28,479
+3,354
| +13% | +$18.4K | ﹤0.01% | 10364 |
|
|
2024
Q2 | $132K | Sell |
25,125
-11,393
| -31% | -$72.4K | ﹤0.01% | 10526 |
|
|
2024
Q1 | $310K | Sell |
36,518
-227,089
| -86% | -$1.98M | ﹤0.01% | 9383 |
|
|
2023
Q4 | $1.74M | Buy |
263,607
+258,132
| +4,715% | +$1.27M | ﹤0.01% | 5615 |
|
|
2023
Q3 | $16.9K | Sell |
5,475
-5,408
| -50% | -$15.6K | ﹤0.01% | 12755 |
|
|
2023
Q2 | $29.4K | Buy |
+10,883
| New | +$31.9K | ﹤0.01% | 12373 |
|
|
2022
Q1 | – | Sell |
-483,897
| Closed | -$4.25M | – | 13824 |
|
|
2021
Q4 | $6.87M | Sell |
483,897
-201,634
| -29% | -$2.25M | ﹤0.01% | 3751 |
|
|
2021
Q3 | $5.49M | Sell |
685,531
-35,170
| -5% | -$559K | ﹤0.01% | 4132 |
|
|
2021
Q2 | $20.6M | Buy |
720,701
+234,042
| +48% | +$6.8M | ﹤0.01% | 2041 |
|
|
2021
Q1 | $14.1M | Buy |
486,659
+85,047
| +21% | +$1.98M | ﹤0.01% | 2461 |
|
|
2020
Q4 | $4.79M | Sell |
401,612
-732
| -0.2% | -$5.15K | ﹤0.01% | 3768 |
|
|
2020
Q3 | $2.78M | Buy |
+402,344
| New | +$2.73M | ﹤0.01% | 4110 |
|
|
2018
Q2 | – | Sell |
-2,682
| Closed | -$10K | – | 8926 |
|
|
2018
Q1 | $10K | Buy |
2,682
+603
| +29% | +$2.51K | ﹤0.01% | 8181 |
|
|
2017
Q4 | $9K | Sell |
2,079
-1,092
| -34% | -$5.68K | ﹤0.01% | 7895 |
|
|
2017
Q3 | $18K | Buy |
3,171
+2,228
| +236% | +$15.5K | ﹤0.01% | 7377 |
|
|
2017
Q2 | $10K | Buy |
+943
| New | +$30.8K | ﹤0.01% | 7372 |
|
Ken Griffin's EPIX Position: Q4 2025 in Review
Ken Griffin sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 144,449 shares — an estimated $27.6K sold.
Ken Griffin first reported a position in EPIX in Q2 2017 and held it in 20 quarters. The position peaked at $20.6M in Q2 2021. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.
- Ken Griffin reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
- Ken Griffin sold 144,449 ESSA Pharma shares in Q4 2025, an estimated $27.6K.
- Ken Griffin first reported a position in ESSA Pharma in Q2 2017 and held it in 20 quarters.
- Ken Griffin's ESSA Pharma position peaked at $20.6M in Q2 2021.
- 0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.